Thursday, March 3, 2022

< + > WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

The WHO panel is also evaluating data for Pfizer’s antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.

No comments:

Post a Comment

< + > Beyond Data Exchange: The Next Era of Interoperability Happens Inside Clinical Workflows

The following is a guest article by Jonathan Shoemaker , CEO at ABOUT Healthcare For a time period that seems like just about forever, the ...